Actionnariat et activité des initiés pour INmune Bio, Inc. (INMB): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.05 |
| Capitalisation | $54M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-08 | SAPIRSTEIN JAMES | |||
| 2026-07-02 | Juda Scott | M-Exempt | 14,801 | $21K |
| 2026-07-02 | Juda Scott | X-InTheMoney | 14,801 | $21K |
| 2026-07-02 | Lowdell Mark William | M-Exempt | 7,211 | $10K |
| 2026-07-02 | Lowdell Mark William | X-InTheMoney | 7,211 | $10K |
| 2026-07-02 | Moss David J | M-Exempt | 9,014 | $13K |
| 2026-07-02 | Moss David J | X-InTheMoney | 9,014 | $13K |
| 2025-12-01 | Moss David J | A-Award | 750,000 | $1.1M |
| 2025-12-01 | Lowdell Mark William | A-Award | 600,000 | $888K |
| 2025-12-01 | Ellspermann Cory Randall | A-Award | 300,000 | $444K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $141659 | $1.4M | $186204 | $7.0M | $22.0M | $74.8M | $52.2M | $35.8M | $20.9M | $24.8M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | 0 | $327608 | $647586 | $645364 | 0 | $5.5M | $8.5M | $2.4M | $1.4M | $4.5M |
| Stocks | 0 | 0 | 0 | -$769.1M | 0 | -$5.5M | $34000 | 0 | 0 | 0 |
| Actifs Courants | $451607 | $1.9M | $849342 | $7.8M | $24.0M | $82.6M | $64.7M | $39.9M | $22.7M | $29.9M |
| Immobilisations Corporelles | 0 | 0 | 0 | $191543 | $156000 | $726000 | $507000 | $414000 | $307000 | $914000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | $16.5M | 0 |
| Actifs Totaux | $451607 | $18.4M | $17.4M | $24.5M | $40.7M | $99.9M | $81.8M | $57.0M | $39.6M | $32.4M |
| Dettes Fournisseurs | $220810 | $136403 | $553221 | $401989 | $1.5M | $3.8M | $5.2M | $7.9M | $6.6M | $7.8M |
| Dette à Court Terme | $350000 | 0 | 0 | 0 | 0 | 0 | $5.0M | $9.9M | 0 | 0 |
| Passifs Courants | $600810 | $309717 | $823766 | $700379 | $1.8M | $4.4M | $10.9M | $18.5M | $7.2M | $8.4M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | $14.5M | $9.7M | 0 | 0 | 0 |
| Passifs Totaux | $600810 | $309717 | $823766 | $860543 | $1.9M | $19.7M | $21.7M | $18.9M | $7.5M | $8.8M |
| Réserves | -$326359 | -$1.2M | -$13.6M | -$21.3M | -$33.4M | -$63.7M | -$91.0M | -$121.0M | -$163.1M | -$209.0M |
| Capitaux Propres | -$149203 | $18.1M | $16.5M | $23.6M | $38.8M | $80.2M | $60.1M | $38.1M | $32.1M | $23.5M |
| Dette Totale | $350000 | 0 | 0 | $168452 | $160000 | $15.2M | $15.3M | $10.4M | $384000 | $1.0M |
| Dette Nette | $208341 | -$1.4M | -$186204 | -$6.8M | -$21.8M | -$59.6M | -$36.8M | -$25.4M | -$20.5M | -$23.7M |
| Fonds de Roulement | -$149203 | $1.6M | $25576 | $7.1M | $22.2M | $78.2M | $53.8M | $21.5M | $15.4M | $21.5M |
Santé financière
| Dette / Capitaux propres | 0.07 |
| Ratio de liquidité | 4.04 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -8.58 |
Rentabilité
| Rentabilité des capitaux propres | -82.87% |
| Rentabilité du capital investi | -92.78% |
| Rentabilité des actifs | -68.60% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ALGS · BRNS · CVM · FGEN · MRSN · OKUR · PDSB
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de INMB: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions